Carregant...

Microdystrophin Gene Therapy of Cardiomyopathy Restores Dystrophin-Glycoprotein Complex and Improves Sarcolemma Integrity in the Mdx Mouse Heart

BACKGROUND: More than 90% of Duchenne muscular dystrophy (DMD) patients develop cardiomyopathy, and many die of cardiac failure. Despite tremendous progress in skeletal muscle gene therapy, few attempts have been made to treat cardiomyopathy. Microdystrophin genes are shown to correct skeletal muscl...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Yue, Yongping, Li, Zhenbo, Harper, Scott Q., Davisson, Robin L., Chamberlain, Jeffrey S., Duan, Dongsheng
Format: Artigo
Idioma:Inglês
Publicat: 2003
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2581719/
https://ncbi.nlm.nih.gov/pubmed/12952841
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/01.CIR.0000089371.11664.27
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!